Archive | Announcements RSS feed for this section

Congratulations to Akers Biosciences Inc. on completion of their merger transaction with MyMD Pharmaceuticals Inc. and listing on Nasdaq.

Leave a comment Continue Reading →

Congratulations to StemoniX (to be renamed Vyant Bio, Inc.) on completion of their combination with Cancer Genetics and listing on Nasdaq.

Leave a comment Continue Reading →

Congratulations to Brooklyn ImmunoTherapeutics, Inc. on its closing of the combination transaction and listing on NYSE American.

Leave a comment Continue Reading →

Congratulations to 4D pharma plc on their business combination with Longevity Acquisition Corporation and listing on Nasdaq.

Completion of Merger with Longevity Acquisition Corporation and admission of American Depositary Shares to trading on NASDAQ Merck Sharp & Dohme to participate in previously announced private placement Gross proceeds of Merger and private placement total approximately $39.8 million   Leeds, UK – 22 March 2021 – 4D pharma plc (AIM: DDDD) (“4D” or the […]

Leave a comment Continue Reading →

Congratulations to Chemomab Therapeutics Ltd. on its closing of the combination transaction and listing on Nasdaq!

Chemomab Completes Merger with Anchiano Therapeutics Shares of Chemomab Therapeutics to commence trading on the Nasdaq Capital Market on March 17, 2021 under the new ticker symbol “CMMB” Combined company will focus on advancing Chemomab’s CM-101 currently in Phase 2 for rare fibrotic indications Company to receive gross proceeds of $45.5 Million from a PIPE […]

Leave a comment Continue Reading →

Virtual 33rd Annual Roth Conference: Dave Donohoe, Roadmap to Uplisting – When, Where and How?

https://wsw.com/webcast/roth35/panel27/2115261  

Leave a comment Continue Reading →

Congratulations to Forian Inc. on its closing of the combination transaction and listing on Nasdaq!

Leave a comment Continue Reading →

Congratulations to Gaucho Group Holdings Inc. on completion of the offering and listing on The Nasdaq Stock Market.

Leave a comment Continue Reading →

Congratulations to Virpax Pharmaceuticals, Inc. on its initial public offering and listing on The Nasdaq Capital Market.

Leave a comment Continue Reading →

Congratulations to GT Biopharma, Inc. on the completion of their $23.65 million public offering and concurrent listing on Nasdaq!

Leave a comment Continue Reading →